Apoptosis Assays Market Research Report - Global Forecast till 2027

Global Apoptosis Assays Research Report: By Product (Kits, Instruments), by Detection Technology (Flow Cytometry, Microscopy), by Application (Drug Discovery and Development), and by End User (Pharmaceutical and Biological, Hospital)—Forecast till 2027

ID: MRFR/LS/5335-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario:


The global apoptosis assays market is expected to grow significantly over the forecast period. The market held a value of USD 2.99 billion in 2017 and is projected to register a CAGR of 9.4% over the forecast period.


Factors such as increasing R&D expense, growing cell-based research, and growing funding for cancer research are expected to propel the growth of the market. However, required high investment for research activities is likely to hamper the market growth over the forecast period. Recently, the National Institutes of Health (NIH) invested USD 1.65 billion for stem cell research in 2017.


Key players:


Abcom plc, Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), Danaher Corporation (US), Becton, Dickinson and Company (US), Sartorius AG (Germany), Geno Technology (US), GeneCopoeia, Inc. (US), and Promega Corporation (US) are some of the key players in the global apoptosis assays market.


Intended Audience



  • Apoptosis assays products manufacturers and vendors

  • Pharmaceutical and biotech companies

  • Contract research organizations

  • Various research and consulting firms


Segmentation:


The global apoptosis assays market has been segmented into product, detection technology, application, and end user.


Based on product, the apoptosis assays market is segmented into kits, reagents, instruments, and others. The kits segment accounted for the largest share segment of the market in 2017.


Based on detection technology, the apoptosis assays market is segmented into flow cytometry, fluorescence microscopy, western blot assessment, gel electrophoresis, and others.


Based on application, the apoptosis assays market is segmented into drug discovery and development, stem cell research, and others.


Based on end user, the apoptosis assays market is segmented into pharmaceutical and biological companies, research institutes, and others.


The apoptosis assays market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The apoptosis assays market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European apoptosis assays market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The apoptosis assays market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The apoptosis assays market in the Middle East and Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Geographically, the Americas is anticipated to dominate the global apoptosis assays market owing to well-established players and increasing R&D expenses.


Europe is expected to hold the second largest position in the global apoptosis assays market. The market growth in this region is attributed to the growth in the pharmaceutical and biotech industry.


The apoptosis assays market in the Asia-Pacific region consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region.


The Middle East and Africa has the least share of the market.


Global Apoptosis Assays Market Share (%), by Region, 2017


Source: Annual Reports and Sec filings


Global Apoptosis Assays Market, by Product



  • Kits

  • Reagents

  • Instruments

  • Others


Global Apoptosis Assays Market, by Detection Technology



  • Flow Cytometry

  • Fluorescence Microscopy

  • Western Blot Assessment

  • Gel Electrophoresis

  • Others


Global Apoptosis Assays Market, by Application



  • Drug Discovery and Development

  • Stem Cell Research

  • Others


Global Apoptosis Assays Market, by End User



  • Pharmaceutical and Biological Companies

  • Research Institutes

  • Others


Global Apoptosis assays Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  •  Middle East & Africa

    • Middle East

    • Africa





Frequently Asked Questions (FAQ) :


The apoptosis assays market is projected to grow at a 9.4% CAGR between 2018-2023.

The Americas is projected to command the largest share in the apoptosis assays market.

Major applications of apoptosis assays include stem cell research and drug discovery development.

Growing funds for cancer research are boosting market growth.

Required high investment for research activities may limit market growth.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

Chapter 6. Global Apoptosis Assays Market, by Product

6.1 Introduction

6.2 Kits

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Reagents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Instruments

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Apoptosis Assays Market, by Detection Technology

7.1 Introduction

7.2 Flow Cytometry

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Fluorescence Microscopy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Western Blot Assessment

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Gel Electrophoresis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Apoptosis Assays Market, by Application

8.1 Introduction

8.2 Drug Discovery And Development

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Stem Cell Research

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Apoptosis Assays Market, by End User

9.1 Introduction

9.2 Pharmaceutical And Biological Companies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Research Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Apoptosis Assays Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Abcom plc

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Merck KGaA

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Bio-Rad Laboratories

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 GE Healthcare

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Danaher Corporation

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Becton, Dickinson and Company

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Sartorius AG

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Geno Technology

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Promega Corporation

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.12 Thermo Fisher Scientific Inc.

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Apoptosis Assays Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Apoptosis Assays Market Synopsis, 2020-2027

Table 2 Global Apoptosis Assays Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Apoptosis Assays Market, by Region, 2020-2027 (USD Million)

Table 4 Global Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

Table 5 Global Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

Table 6 Global Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

Table 7 Global Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

Table 8 North America: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

Table 9 North America: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

Table 10 North America: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

Table 11 North America: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

Table 12 US: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

Table 13 US: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

Table 14 US: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

Table 15 US: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

Table 16 Canada: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

Table 17 Canada: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

Table 18 Canada: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

Table 19 Canada: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

Table 20 South America: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

Table 21 South America: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

Table 22 South America: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

Table 23 South America: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

Table 24 Europe: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

Table 25 Europe: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

Table 26 Europe: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

Table 27 Europe: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

Table 28 Western Europe: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

Table 29 Western Europe: Apoptosis Assays Market, by Detection Technology, 2020-2027

(USD Million)

Table 30 Western Europe: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

Table 31 Western Europe: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

Table 32 Eastern Europe: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

Table 33 Eastern Europe: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

Table 34 Eastern Europe: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

Table 35 Eastern Europe: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

Table 36 Asia-Pacific: Apoptosis Assays Market, by Product, 2020-2027 (USD Million)

Table 37 Asia-Pacific: Apoptosis Assays Market, by Detection Technology, 2020-2027 (USD Million)

Table 38 Asia-Pacific: Apoptosis Assays Market, by Application, 2020-2027 (USD Million)

Table 39 Asia-Pacific: Apoptosis Assays Market, by End User, 2020-2027 (USD Million)

Table 40 Middle East & Africa: Apoptosis Assays Market, by Product, 2020-2027

(USD Million)

Table 41 Middle East & Africa: Apoptosis Assays Market, by Detection Technology, 2020-2027

(USD Million)

Table 42 Middle East & Africa: Apoptosis Assays Market, by Application, 2020–

2027 (USD Million)

Table 43 Middle East & Africa: Apoptosis Assays Market, by End User, 2020–

2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Global Apoptosis Assays Market

Figure 3 Market Dynamics for Global Apoptosis Assays Market

Figure 4 Global Apoptosis Assays Market Share, by Product, 2020

Figure 5 Global Apoptosis Assays Market Share, by Detection Technology, 2020

Figure 6 Global Apoptosis Assays Market Share, by Application, 2020

Figure 7 Global Apoptosis Assays Market Share, by End User, 2020

Figure 8 Global Apoptosis Assays Market Share, by Region, 2020

Figure 9 North America: Apoptosis Assays Market Share, by Country, 2020

Figure 10 Europe: Apoptosis Assays Market Share, by Country, 2020

Figure 11 Asia-Pacific: Apoptosis Assays Market Share, by Country, 2020

Figure 12 Middle East & Africa: Apoptosis Assays Market Share, by Country, 2020

Figure 13 Global Apoptosis Assays Market: Company Share Analysis, 2020 (%)

Figure 14 Abcom plc: Key Financials

Figure 15 Abcom plc: Segmental Revenue

Figure 16 Abcom plc: Geographical Revenue

Figure 17 Merck KGaA: Key Financials

Figure 18 Merck KGaA: Segmental Revenue

Figure 19 Merck KGaA: Geographical Revenue

Figure 20 Bio-Rad Laboratories: Key Financials

Figure 21 Bio-Rad Laboratories: Segmental Revenue

Figure 22 Bio-Rad Laboratories: Geographical Revenue

Figure 23 GE Healthcare: Key Financials

Figure 24 GE Healthcare: Segmental Revenue

Figure 25 GE Healthcare: Geographical Revenue

Figure 26 DANAHER CORPORATION: Key Financials

Figure 27 DANAHER CORPORATION: Segmental Revenue

Figure 28 DANAHER CORPORATION. Geographical Revenue

Figure 29 Becton, Dickinson and Company: Key Financials

Figure 30 Becton, Dickinson and Company: Segmental Revenue

Figure 31 Becton, Dickinson and Company: Geographical Revenue

Figure 32 Sartorius AG: Key Financials

Figure 33 Sartorius AG: Segmental Revenue

Figure 34 Sartorius AG: Geographical Revenue

Figure 35 Geno Technology: Key Financials

Figure 36 Geno Technology: Segmental Revenue

Figure 37 Geno Technology: Geographical Revenue

Figure 38 Thermo Fisher Scientific Inc: Key Financials

Figure 39 Thermo Fisher Scientific Inc: Segmental Revenue

Figure 40 Thermo Fisher Scientific Inc: Geographical Revenue

Figure 41 Promega Corporation: Key Financials

Figure 42 Promega Corporation: Segmental Revenue

Figure 43 Promega Corporation: Geographical Revenue